BRIDGE – Blocking Receptor of IL-1β for Donor Graft Edema Reduction

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Lung Transplant Recipient Interventions: Drug: Anakinra Sponsors: Northwestern University Not yet recruiting Conditions: Lung Transplant Recipient Interventions: Drug: Anakinra Sponsors: Northwestern University Not yet...

Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once – Versus Twice – Weekly Sessions on Outcomes in Depression.

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Depression – Major Depressive Disorder; Cognitive Behavior Therapy; Psychodynamic Therapy Interventions: Behavioral: Cognitive behavior therapy; Behavioral: Psychodynamic therapy Sponsors: University of Oslo Not yet recruiting Conditions:...

Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Breast Cancer; Pain and Fear During Intramuscular Hormone Injections Interventions: Device: ShotBlocker device; Procedure: This involves rhythmic, gentle tapping with the fingertips on the skin surrounding the gluteal injection site. Sponsors: Inonu...

Diagnostic Accuracy of Oral Images, OPGs, Biomarkers and Questionnaires vs. Clinical Assessment for Periodontal Disease (PostNCT07164573)

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Periodontal Disease; Gingivitis; Periodontitis Sponsors: Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University; University of Chieti; King’s College London; University of Roma La Sapienza; University of Turin, Italy Not...

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride (normal saline) Sponsors: siRNAgen Therapeutics Inc. Recruiting Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride...